P4 Precision Medicine

What P4 Precision Medicine does

P4 Precision Medicine Accelerator is a London-headquartered venture builder, incubator, accelerator, and fund founded in 2019 by Nathan McNally. Operating under the '4 Ps' framework (predictive, preventative, participatory, personalised medicine), the company runs cohort-based 6-12 month scale-up programmes for early-to-mid-stage precision medicine startups across digital health, medtech, biotech, and therapeutics. Its core offering is the P4 Programme, which provides selective applicants with dedicated workshops, one-to-one expert mentoring, regulatory pathway support, clinical testbeds, and curated introductions to investors, NHS partners, and academic institutions including UCL, Oxford, Cambridge, and King's College London. Since founding, P4 has supported over 250 companies, helped portfolio companies raise more than £300M in investment and secure over £100M in R&D funding, and recorded five successful exits across eight cohorts.

The business model combines services-for-equity and subsidised programme fees across three physical locations: the IDEALondon headquarters (London), the P4SY regional programme (South Yorkshire, launched 2021 and part-funded by ERDF), and the P4 Precision Medicine Innovation Centre Beijing (opened 2024 at Yizhuang's Beijing Economic and Technological Development Zone). The Beijing centre offers up to £50,000 in landing investment, free office space, and subsidised market analysis, functioning as a bilateral UK-China market entry platform backed by the UK Department for Business & Trade and Zhongguancun Development Group. Go-to-market is event-driven and application-based, supported by international bootcamps in Beijing and Xiamen, content marketing, and partnerships with AstraZeneca, Pharmaron, and XtalPi. The company employs 1-10 people and is founder-led, with the second-generation leadership cohort including Raine Chen as International Project Manager and Philip Beales as Founder and Director.

Name

P4 Precision Medicine

Legal name

P4 Precision Medicine Accelerator

Website

https://p4precisionmedicine.co.uk

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

P4 Precision Medicine is a UK-based precision medicine accelerator and venture builder running cohort-based 6-12 month programmes for early-to-mid-stage digital health, medtech, biotech, and therapeutics startups, with hubs in London, South Yorkshire, and Beijing serving portfolio companies seeking regulatory, clinical, and capital support.

Ownership category

akta.pro rank

Product category

Healthcare Startup Accelerator Services

NAICS

Scientific Research and Development Services (5417)

SIC

Investment Advice (6282)

akta.pro primary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

akta.pro secondary industries

Regulatory Affairs & Submissions FSP (HLAGAOAD), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

Keywords

• Precision medicine accelerator
• Healthcare startup incubator
• Venture builder programs
• Medtech market entry
• Biotech scale-up support

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Accelerator Programme Services: P4 operates as a venture builder, incubator, accelerator, and fund. The programme supports companies through development, regulation, investment, adoption and scale to UK and international markets. The accelerator provides services in exchange for equity or programme fees.
2. P4 Beijing - Investment and Landing Support: Companies can receive up to £50,000 investment upon landing in the Beijing centre with a period of free office space. The programme is subsidised to cover most costs of initial market analysis, travel and attending events and conferences.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

P4 Precision Medicine Accelerator operates a 6-12 month cohort-based scale-up programme that selects early-to-mid-stage precision medicine startups and provides mentorship, dedicated workshops, 1-1 expert advice, regulatory pathway support, testbeds, and investor introductions. The programme runs physical cohorts from London and South Yorkshire, with an additional P4 Beijing Innovation Centre offering subsidised market entry support (up to £50,000 investment and free office space) for UK and international companies entering China. As a venture builder, incubator, accelerator, and fund, P4 supports companies through development, regulation, investment, adoption, and international scale across digital health, medtech, biotech, and therapeutics.

Product overview

P4 Precision Medicine Accelerator is a venture builder, incubator, accelerator, and fund that operates multiple programmes to support precision medicine startups. The core offerings include the P4 Programme (a 6-12 month scale-up accelerator connecting startups with mentors, investors, and academia) and the P4 Precision Medicine Innovation Centre Beijing (a market entry programme supporting entry into the China market). The organisation focuses on innovations that make medicine more predictive, preventative, participatory, and personalised (the "4 Ps"), spanning digital health, medtech, biotech, and therapeutics.

Differentiator

Problem solved

Functional benefit

Products and services

• P4 Programme (Scale-up Accelerator) A 6-12 month cohort-based scale-up programme connecting early-to-mid-stage precision medicine startups with academia, industry, and healthcare sectors. Provides workshops, expert 1-1 advice, networking, and investment connections to support startups through development, regulatory approval, investment, adoption, and scale across UK and international markets.
• P4 Precision Medicine Innovation Centre Beijing A subsidised market entry programme for UK and international health and life science companies entering China. Provides education on regulatory and market dynamics, pre-landing analysis, delegations, customer matching, mentoring, up to £50,000 investment upon landing, and a period of free office space.

Quantifiable outcome

• £300M+ investment raised by portfolio companies
• +5 more outcomes

Named customers18 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

33 partnerships are on record, tiered core, supporting and minor.

• UK Department for Business & TradecoreStrategic or Co-development Partner · 1 January 2024Government partner supporting UK-China health innovation collaboration and trade missions
• ITTN (International Technology Transfer Network)coreStrategic or Co-development PartnerInternational technology transfer network supporting cross-border innovation partnerships
• CIPAcoreStrategic or Co-development PartnerChina International Patent Protection Association supporting IP protection for international companies
• Peking University Third HospitalcoreStrategic or Co-development PartnerAcademic medical centre supporting clinical partnerships and research collaborations
• Globaltech IPcoreImplementation/ SI/ Consulting PartnerIP services partner supporting patent protection and technology transfer
• TEAM-SY (South Yorkshire)coreStrategic or Co-development PartnerEcosystem acceleration programme supporting South Yorkshire health tech development, part-funded by ERDF
• UCLcoreStrategic or Co-development PartnerUniversity College London - academic partner supporting research and company spinouts
• King's College LondoncoreStrategic or Co-development PartnerAcademic partner supporting health innovation and clinical research
• University of OxfordcoreStrategic or Co-development PartnerAcademic partner supporting biotech and medtech innovation
• University of CambridgecoreStrategic or Co-development PartnerAcademic partner supporting technology transfer and spinouts
• Queen Mary University of LondonsupportingStrategic or Co-development PartnerAcademic partner supporting health innovation research
• IDEALondoncoreStrategic or Co-development PartnerInnovation hub providing physical space and ecosystem support for health tech companies
• XtalPi Inc.supportingStrategic or Co-development PartnerPharmaceutical technology company supporting drug discovery innovation
• PharmaronsupportingStrategic or Co-development PartnerPharmaceutical services company supporting drug development
• AstraZenecasupportingStrategic or Co-development PartnerPharmaceutical company supporting healthcare innovation ecosystem
• Tsinghua UniversitysupportingStrategic or Co-development PartnerLeading Chinese university supporting research collaborations
• Changgeng HospitalsupportingStrategic or Co-development PartnerMedical institution supporting clinical partnerships in China
• Zhongguancun Development GroupcoreStrategic or Co-development PartnerBeijing development zone supporting innovation ecosystem and company landing
• Beijing Science Park Development GroupcoreStrategic or Co-development PartnerStrategic collaboration formalised at Zhongguancun Forum supporting innovation centre partnerships
• ThorgenecoreStrategic or Co-development PartnerLaunch of P4-Thorgene Genomics Diagnostics Laboratory at Zhongguancun Forum
• Cambridge EnterprisecoreStrategic or Co-development PartnerTechnology transfer office supporting university spinouts and innovation
• Nuffield HealthcoreStrategic or Co-development PartnerHealthcare provider supporting clinical validation and health innovation
• UCLPartnerscoreStrategic or Co-development PartnerAcademic health science partnership supporting clinical research and innovation
• Bioindustry Association (BIA)supportingStrategic or Co-development PartnerIndustry body representing UK bioscience sector
• CAP-AIsupportingStrategic or Co-development PartnerAI accelerator programme for healthcare and life sciences in London
• VasoDynamicsminorStrategic or Co-development PartnerUK company participating in UK Precision Medicine delegation at Zhongguancun Forum focusing on therapeutics addressing side effects of cancer treatment
• CureneticsminorStrategic or Co-development PartnerUK company participating in UK delegation with AI platform predicting immunotherapy response
• Oxford VacmedixminorStrategic or Co-development PartnerUK company participating in delegation with cancer immunotherapy platform
• Tolemy BiominorStrategic or Co-development PartnerUK company in delegation with digital twin platform for biomanufacturing
• abYCloudminorStrategic or Co-development PartnerUK company in delegation with SaaS platform for antibody drug development
• UniqgeneminorStrategic or Co-development PartnerCompany in delegation with personalised genetics testing platform for sports performance
• SleepUpminorStrategic or Co-development PartnerCompany in delegation with digital therapeutics and EEG-based diagnostics
• AtelerixminorStrategic or Co-development PartnerCompany in delegation with ambient-temperature biostorage and transport technology

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Cambridge Enterprise: University of Cambridge's technology transfer and venture arm supporting spinouts across biotech, medtech, and deeptech. Overlaps with P4 in sourcing and supporting Cambridge-originated precision medicine startups.
• Oxford Science Innovation (OSI): Large UK university-linked deeptech and life sciences investor and venture builder spun out of Oxford. Comparable in supporting precision medicine spinouts but operates as a much larger, well-capitalised fund rather than a cohort accelerator.

Direct peers

• Digital Health London: NHS-affiliated London digital health accelerator supporting early-stage healthtech companies through mentorship, NHS navigation, and investor introductions. Overlaps directly with P4's London cohort offering and target customer profile.
• IndieBio: US-based biotech accelerator with a London presence, running cohort-based programmes for biology and healthtech startups. Most directly comparable to P4 in mission, cohort structure, and equity-for-support model, though IndieBio typically operates at larger cheque sizes.
• BioCity: UK-based life sciences incubator and accelerator providing lab space, mentorship, and investor access to early-stage health and biotech companies. Highly comparable in target founder segment, geography, and service offering.
• NHS Innovation Accelerator: UK national programme supporting adoption of evidence-based innovations in the NHS. Comparable in providing market access and validation support to healthtech founders, with a similar cohort-style mentoring model.
• Imperial White City Incubator: Imperial College London's deeptech and healthtech incubator providing lab space and venture support to spinouts. Comparable in London-based healthtech focus and academic spinout sourcing.
• Startupbootcamp Health (Techstars): Digital health accelerator operating cohort-based programmes with mentor networks, investor introductions, and office space. Comparable in cohort structure and enterprise/healthtech focus, though broader in geography and verticals.

Regional players

• ChinaBio Partnering: China-focused life sciences partnering and accelerator network supporting cross-border deal flow. Comparable to P4's Beijing centre in enabling UK/international life sciences companies to engage with the Chinese market.
• BioM (Munich): Germany's leading biotech cluster and accelerator network providing infrastructure, mentoring, and capital access to European biotech startups. Comparable mission and cohort offering but focused on the DACH region.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/p4precision
• LinkedInlinkedin.com/company/p4pma

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about P4 Precision Medicine